Surrey Clinical Trials Unit (CTU) is part of the Faculty of Health and Medical Sciences (FHMS) at the University of Surrey. Surrey CTU is an academic trials unit that has the experience, expertise and infrastructure to develop, organise and manage high quality, multi-centre, randomised controlled trials (including trials of Investigational Medicinal Products) of national and international importance.
Surrey CTU has proven expertise in trial design and management in disease areas such as Cancer, Gastroenterology, Palliative Care and Endocrinology. It supports trials at all phases from First in Human (FIH) through to large scale pragmatic trials as well as trials of complex interventions.
The CTU works closely and is associated with Surrey Clinical Research Facility (formerly Surrey Clinical Research Centre) in the delivery of early phase studies.
Early Phase Trials
We partner with investigators at a local and national level to deliver high quality trials that directly influence clinical practice nationally and internationally. We have experienced staff who can work with researchers in developing and delivering research for MRC, NIHR, HTA, CRUK and other grant awarding bodies.
Surrey CTU has close working relationships with Royal Surrey NHS Foundation Trust (RSFT), University of Surrey Health Partners, the Kent Surrey Sussex Academic Health Science Network (KSS AHSN) and other national Clinical Trials Units through the UK CRC Registered Clinical Trials Units Network.
The CTU works closely with the Surrey hub of the NIHR Research Design Service South East (RDS SE) and Surrey Health Economics Centre (SHEC) to offer support and advice on funding applications and all aspects of study design and methodology, including health economic evaluation and trial management.
Contact us if you would like Surrey CTU to either develop your research ideas or conduct a clinical trial.